Neurogene Statistics
Share Statistics
Neurogene has 20.98M shares outstanding. The number of shares has increased by 63.23% in one year.
| Shares Outstanding | 20.98M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 61.46% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 16.17M |
| Failed to Deliver (FTD) Shares | 6.74K |
| FTD / Avg. Volume | 1.69% |
Short Selling Information
The latest short interest is 914.19K, so 4.36% of the outstanding shares have been sold short.
| Short Interest | 914.19K |
| Short % of Shares Out | 4.36% |
| Short % of Float | 5.65% |
| Short Ratio (days to cover) | 7.15 |
Valuation Ratios
The PE ratio is -6.84 and the forward PE ratio is -8.62.
| PE Ratio | -6.84 |
| Forward PE | -8.62 |
| PS Ratio | 0 |
| Forward PS | 816.3 |
| PB Ratio | 1.34 |
| P/FCF Ratio | -4.8 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Neurogene Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.72, with a Debt / Equity ratio of 0.
| Current Ratio | 8.72 |
| Quick Ratio | 8.72 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -4631.92 |
Financial Efficiency
Return on equity (ROE) is -0.2% and return on capital (ROIC) is -27.48%.
| Return on Equity (ROE) | -0.2% |
| Return on Assets (ROA) | -0.16% |
| Return on Capital (ROIC) | -27.48% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -399.09K |
| Employee Count | 91 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -44.27% in the last 52 weeks. The beta is 0, so Neurogene 's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | -44.27% |
| 50-Day Moving Average | 29.76 |
| 200-Day Moving Average | 36.53 |
| Relative Strength Index (RSI) | 31 |
| Average Volume (20 Days) | 398.04K |
Income Statement
| Revenue | n/a |
| Gross Profit | -3.26M |
| Operating Income | -55.58M |
| Net Income | -36.32M |
| EBITDA | -52.29M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -2.83 |
Balance Sheet
The company has 148.21M in cash and 16.25M in debt, giving a net cash position of 131.96M.
| Cash & Cash Equivalents | 148.21M |
| Total Debt | 16.25M |
| Net Cash | 131.96M |
| Retained Earnings | -187.15M |
| Total Assets | 164.12M |
| Working Capital | 127.85M |
Cash Flow
In the last 12 months, operating cash flow was -51.42M and capital expenditures -321.00K, giving a free cash flow of -51.74M.
| Operating Cash Flow | -51.42M |
| Capital Expenditures | -321.00K |
| Free Cash Flow | -51.74M |
| FCF Per Share | -4.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NGNE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -15.72% |
| FCF Yield | -13.71% |
Analyst Forecast
The average price target for NGNE is $60, which is 233.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $60 |
| Price Target Difference | 233.3% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Stock Splits
The last stock split was on Dec 19, 2023. It was a backward split with a ratio of 1:4.
| Last Split Date | Dec 19, 2023 |
| Split Type | backward |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | 8.24 |
| Piotroski F-Score | 1 |